KETOCONAZOLE (NIZORAL)

Course overview

Ketoconazole is U.S. FDA-approved to treat systemic and cutaneous fungal infections caused by susceptible organisms. It is contraindicated in patients with acute or chronic liver disease, and must be used cautiously in patients with achlorhydria. This continuing education module is designed to give the reader/learner an increased understanding of ketoconazole. Readers may explore any or all of the topics. One contact hour of continuing education credit is available for those who successfully complete the post-test and evaluation form.